Trending

Corbevax Vaccine Gets Emergency Use Approval For 12-18 Yr Age Group In India

Biological E Limited's Corbevax COVID vaccine, the first indigenously developed in India Receptor Binding Domain (RBD) protein subunit vaccine against the novel virus, has finally acquired emergency use authorisation (EUA) from the nation's drug regulator for the 12 to 18 years age group.The Drugs...